231 related articles for article (PubMed ID: 18223688)
1. Aberrant promoter methylation and tumor suppressive activity of the DFNA5 gene in colorectal carcinoma.
Kim MS; Chang X; Yamashita K; Nagpal JK; Baek JH; Wu G; Trink B; Ratovitski EA; Mori M; Sidransky D
Oncogene; 2008 Jun; 27(25):3624-34. PubMed ID: 18223688
[TBL] [Abstract][Full Text] [Related]
2. Identification of methylation-silenced genes in colorectal cancer cell lines: genomic screening using oligonucleotide arrays.
Fukutomi S; Seki N; Koda K; Miyazaki M
Scand J Gastroenterol; 2007 Dec; 42(12):1486-94. PubMed ID: 17994469
[TBL] [Abstract][Full Text] [Related]
3. Large-scale analysis of
Croes L; Beyens M; Fransen E; Ibrahim J; Vanden Berghe W; Suls A; Peeters M; Pauwels P; Van Camp G; Op de Beeck K
Clin Epigenetics; 2018; 10():51. PubMed ID: 29682089
[TBL] [Abstract][Full Text] [Related]
4. Methylation of the DFNA5 increases risk of lymph node metastasis in human breast cancer.
Kim MS; Lebron C; Nagpal JK; Chae YK; Chang X; Huang Y; Chuang T; Yamashita K; Trink B; Ratovitski EA; Califano JA; Sidransky D
Biochem Biophys Res Commun; 2008 May; 370(1):38-43. PubMed ID: 18346456
[TBL] [Abstract][Full Text] [Related]
5. Methylation of the DFNA5 gene is frequently detected in colorectal cancer.
Yokomizo K; Harada Y; Kijima K; Shinmura K; Sakata M; Sakuraba K; Kitamura Y; Shirahata A; Goto T; Mizukami H; Saito M; Kigawa G; Nemoto H; Hibi K
Anticancer Res; 2012 Apr; 32(4):1319-22. PubMed ID: 22493364
[TBL] [Abstract][Full Text] [Related]
6. Altered regulation of DNA ligase IV activity by aberrant promoter DNA methylation and gene amplification in colorectal cancer.
Kuhmann C; Li C; Kloor M; Salou M; Weigel C; Schmidt CR; Ng LW; Tsui WW; Leung SY; Yuen ST; Becker N; Weichenhan D; Plass C; Schmezer P; Chan TL; Popanda O
Hum Mol Genet; 2014 Apr; 23(8):2043-54. PubMed ID: 24282031
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA 345, a methylation-sensitive microRNA is involved in cell proliferation and invasion in human colorectal cancer.
Tang JT; Wang JL; Du W; Hong J; Zhao SL; Wang YC; Xiong H; Chen HM; Fang JY
Carcinogenesis; 2011 Aug; 32(8):1207-15. PubMed ID: 21665895
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic silencing of LRRC3B in colorectal cancer.
Tian XQ; Zhang Y; Sun D; Zhao S; Xiong H; Fang J
Scand J Gastroenterol; 2009; 44(1):79-84. PubMed ID: 18815942
[TBL] [Abstract][Full Text] [Related]
9. Identification of DFNA5 as a target of epigenetic inactivation in gastric cancer.
Akino K; Toyota M; Suzuki H; Imai T; Maruyama R; Kusano M; Nishikawa N; Watanabe Y; Sasaki Y; Abe T; Yamamoto E; Tarasawa I; Sonoda T; Mori M; Imai K; Shinomura Y; Tokino T
Cancer Sci; 2007 Jan; 98(1):88-95. PubMed ID: 17083569
[TBL] [Abstract][Full Text] [Related]
10. Cysteine dioxygenase 1 is a tumor suppressor gene silenced by promoter methylation in multiple human cancers.
Brait M; Ling S; Nagpal JK; Chang X; Park HL; Lee J; Okamura J; Yamashita K; Sidransky D; Kim MS
PLoS One; 2012; 7(9):e44951. PubMed ID: 23028699
[TBL] [Abstract][Full Text] [Related]
11. Aging related methylation influences the gene expression of key control genes in colorectal cancer and adenoma.
Galamb O; Kalmár A; Barták BK; Patai ÁV; Leiszter K; Péterfia B; Wichmann B; Valcz G; Veres G; Tulassay Z; Molnár B
World J Gastroenterol; 2016 Dec; 22(47):10325-10340. PubMed ID: 28058013
[TBL] [Abstract][Full Text] [Related]
12. Genome-wide screening for methylation-silenced genes in colorectal cancer.
Khamas A; Ishikawa T; Mogushi K; Iida S; Ishiguro M; Tanaka H; Uetake H; Sugihara K
Int J Oncol; 2012 Aug; 41(2):490-6. PubMed ID: 22664866
[TBL] [Abstract][Full Text] [Related]
13. Semaphorin-3F functions as a tumor suppressor in colorectal cancer due to regulation by DNA methylation.
Gao X; Tang C; Shi W; Feng S; Qin W; Jiang T; Sun Y
Int J Clin Exp Pathol; 2015; 8(10):12766-74. PubMed ID: 26722466
[TBL] [Abstract][Full Text] [Related]
14. The N-methyl-D-aspartate receptor type 2A is frequently methylated in human colorectal carcinoma and suppresses cell growth.
Kim MS; Chang X; Nagpal JK; Yamashita K; Baek JH; Dasgupta S; Wu G; Osada M; Woo JH; Westra WH; Trink B; Ratovitski EA; Moon C; Sidransky D
Oncogene; 2008 Mar; 27(14):2045-54. PubMed ID: 17922030
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of B-Cell Translocation Gene 1 by Promoter Methylation in Colorectal Carcinoma.
Jung YY; Sung JY; Kim JY; Kim HS
Anticancer Res; 2018 Feb; 38(2):691-697. PubMed ID: 29374692
[TBL] [Abstract][Full Text] [Related]
16. Identification of genes epigenetically silenced by CpG methylation in human gastric carcinoma.
Jee CD; Kim MA; Jung EJ; Kim J; Kim WH
Eur J Cancer; 2009 May; 45(7):1282-1293. PubMed ID: 19195878
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer.
Toyota M; Suzuki H; Sasaki Y; Maruyama R; Imai K; Shinomura Y; Tokino T
Cancer Res; 2008 Jun; 68(11):4123-32. PubMed ID: 18519671
[TBL] [Abstract][Full Text] [Related]
18. Statins augment the chemosensitivity of colorectal cancer cells inducing epigenetic reprogramming and reducing colorectal cancer cell 'stemness' via the bone morphogenetic protein pathway.
Kodach LL; Jacobs RJ; Voorneveld PW; Wildenberg ME; Verspaget HW; van Wezel T; Morreau H; Hommes DW; Peppelenbosch MP; van den Brink GR; Hardwick JC
Gut; 2011 Nov; 60(11):1544-53. PubMed ID: 21551187
[TBL] [Abstract][Full Text] [Related]
19. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.
Melotte V; Lentjes MH; van den Bosch SM; Hellebrekers DM; de Hoon JP; Wouters KA; Daenen KL; Partouns-Hendriks IE; Stessels F; Louwagie J; Smits KM; Weijenberg MP; Sanduleanu S; Khalid-de Bakker CA; Oort FA; Meijer GA; Jonkers DM; Herman JG; de Bruïne AP; van Engeland M
J Natl Cancer Inst; 2009 Jul; 101(13):916-27. PubMed ID: 19535783
[TBL] [Abstract][Full Text] [Related]
20. Promoter hypermethylation of the ADAM23 gene in colorectal cancer cell lines and cancer tissues.
Choi JS; Kim KH; Jeon YK; Kim SH; Jang SG; Ku JL; Park JG
Int J Cancer; 2009 Mar; 124(6):1258-62. PubMed ID: 19089928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
